Current Genomics is a peer-reviewed journal that provides essential reading for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments in genome science and systems modeling.
Current Genomics publishes three types of peer-reviewed articles including:
- i) High-quality research papersreporting on new and original data generated at the genome scale level, including meta-analysis studies. Systems biology, molecular systems modeling, molecular evolution, developmental biology, aging research and human disease research are topics of particular interest. Position papers dealing with new or complex methodological approaches whether experimental or mathematical are greatly welcome in this section.
- ii) Authoritative and comprehensive reviewsfrom widely-recognized experts, covering all the latest and outstanding developments in genome science and computational/systems biology. Proposals for mini-hot topics (2-3 review papers) and full hot topics (6-8 review papers) are welcome in this section and they should not contain original data. Guest edited issues provide expert views on specific questions giving an extensive and comprehensive analysis of a specific field of activities in genomics. All aspects of genetic analysis and gene function will be covered, particularly in the growing areas of human genomics, functional genomics and next generation sequencing, molecular evolution, developmental biology, aging research and systems/statistical modeling.
iii) Opinion papers from internationally and widely recognized experts addressing contemporary questions and issues in the field of genome science and systems biology and basic and clinical research practices.
Articles from the journal Current Genomics, Volume 17, Issue 4:
For details on the articles, please visit this link :: http://bit.ly/2aixpmz
Editor-in-Chief: Current Clinical Pharmacology
Dr. Arduino A. Mangoni
Department of Clinical Pharmacology,
Clinical Pharmacologist and General Physician,
Flinders University and Flinders Medical Centre,
Bedford Park, SA 5042,
Editor Board Member: Recent Advances in Cardiovascular Drug Discovery
Dr. Paul J. Higgins
Director, Center for Cell Biology & Cancer Research,
Albany Medical College 47 New Scotland Avenue,
Albany, New York 12208
Scientists from Toronto, Canada went on to study autism, ADHD and OCD focusing on the changes in brains of children suffering from these dreaded disorders. Their findings revealed that all the three are quite closely related. Our brains have white matter which determines our connectivity with the outside world, the way we concentrate, remember, interact with others and surroundings and our overall behavior.
The white matter carries network of neurons covering the brain. The scientist found that the patients of ADHD, autism and OCD had impaired tract of white matter joining the right and the left hemisphere. This impairment is more severe in autistic children and ADHD sufferers than in children with Obsessive Compulsive Disorder. This could be imagined as the latter is not as distinctly visible than the former two. Still the symptoms are much the same and primarily show as behavioral problem.
For a long time the researchers have been studying them all separately but now they can be seen under same scope.
Current Hypertension Reviews publishes frontier reviews, original research articles and guest edited thematic issues on all the latest advances on hypertension and its related areas e.g. nephrology, clinical care, and therapy. The journal’s aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all clinicians and researchers in the field of hypertension.
Articles from the journal Current Hypertension Reviews, Volume 12, Issue 2:
For details on the articles, please visit this link :: http://bit.ly/29YLaYr
Central Nervous System Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new central nervous system agents.
Containing a series of timely in-depth reviews, original research articles, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics, Central Nervous System Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in the field.
Articles from the journal Central Nervous System Agents in Medicinal Chemistry, Volume 16, Issue 2:
For details on the articles, please visit this link :: http://bit.ly/2avYW5F